People at risk of coronary heart disease should not be denied treatment with effective drugs for purely financial reasons

Comment

T M Reynolds et al. BMJ. 1998.

. 1998 Jul 4;317(7150):80.

doi: 10.1136/bmj.317.7150.80.

No abstract available

Comment on

Effectiveness of health checks conducted by nurses in primary care: final results of the OXCHECK study. Imperial Cancer Research Fund OXCHECK Study Group.
[No authors listed] [No authors listed] BMJ. 1995 Apr 29;310(6987):1099-104. BMJ. 1995. PMID: 7742676 Free PMC article. Clinical Trial.
Use of statins. Standing Medical Advisory Committee should reconsider advice to use Sheffield risk table.
Reynolds TM. Reynolds TM. BMJ. 1997 Dec 13;315(7122):1620. BMJ. 1997. PMID: 9437298 Free PMC article. No abstract available.

1. NHS Executive. SMAC statement on use of statins. Wetherby, West Yorkshire: Department of Health; 1997. (Executive letter EL(97)41.)
1. 103 experts. Use of statins: standing medical advisory committee should reconsider advice to use Sheffield risk table. BMJ. 1997;315:1620. . (letter.) - PMC - PubMed
1. NHS Centre for Reviews and Dissemination. Cholesterol and coronary heart disease. EffectiveHealth Care Bull 1998;4.
1. Anonymous Imperial Cancer Research Fund OXCHECK Study Group. Effectiveness of health checks conducted by nurses in primary care: results of the OXCHECK study. BMJ. 1996;310:1099–1104. - PMC - PubMed
1. Shepherd J. Identification of high risk groups and comparison with other cardiovascular intervention trials. Lancet. 1996;348:1339–1342. - PubMed